NEW YORK (GenomeWeb News) – Roche and Labcyte today announced they will be working together to integrate their systems to monitor the expression of genes for therapeutic research.
The deal will couple Roche's RealTime ready Cell Lysis kits with Labcyte's Echo liquid handlers and newly released tissue culture microplates, enabling researchers to simplify high-throughput qPCR analyses. The process can be full automated on Labcyte's Access Workstation, which integrates the Echo liquid handler with either the LightCycler 480 or LightCycler 1536 instrument from Roche, the companies added.
They added that "[g]ene expression profiles derived in a one-step process directly from cells can now be streamlined into a simple automated workflow, significantly increasing productivity."
Financial and other terms were not disclosed.